Lansoprazol

Lansoprazole is a medication that belongs to the class of drugs known as proton pump inhibitors (PPIs). It is primarily used to reduce stomach acid production and is commonly prescribed for conditions related to excess acid, such as gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, and peptic ulcers. By inhibiting the proton pump in the gastric parietal cells, lansoprazole effectively decreases the secretion of hydrochloric acid, thereby alleviating symptoms and promoting healing of acid-related mucosal damage.

Lansoprazole is typically administered orally in the form of capsules or dissolvable tablets. The dosage and duration of treatment depend on the specific condition and its severity. It is usually taken before meals to maximize its effectiveness. The drug is rapidly absorbed, with peak plasma concentrations occurring within 1 to 3 hours after administration.

Common side effects of lansoprazole may include headache, diarrhea, nausea, abdominal pain, and constipation. Serious adverse effects are rare but can include allergic reactions, bone fractures with prolonged use, and hypomagnesemia. Long-term use of PPIs has been associated with increased risks of certain infections such as Clostridioides difficile, as well as potential nutrient malabsorption, including magnesium, calcium, and vitamin B12.

Lansoprazole is generally considered safe when used appropriately under medical supervision. It is available by prescription and, in some regions, as an over-the-counter medication. Due to potential drug interactions and contraindications, patients should consult healthcare professionals before initiating treatment, especially if they have underlying health conditions or are taking other medications.

References:

1. Katz PO, Gerson LB, Vela MF. "Guidelines for the diagnosis and management of gastroesophageal reflux disease." The American Journal of Gastroenterology, 2013.

2. Moayyedi P, et al. "Long-term proton pump inhibitor therapy and risk of Clostridioides difficile infection." Eur J Clin Microbiol Infect Dis, 2017.